Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Modafinil Have Pro-cognitive Effects in Those With Residual Cognitive Impairment Despite Remitted Depression?

NCT03620253 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT03620253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03620253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Modafinil Have Pro-cognitive Effects in Those With Residual Cognitive Impairment Despite Remitted Depression?
Lead sponsor
Unity Health Toronto
Phase
Phase 3
Overall status
Terminated
Start date
October 15, 2018
Completion date
August 6, 2019
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, major depressive disorder